of 240 patients with type iia and iib hypercholesterolemia recruited in 11 centers , 227 were randomized to double-blind treatment with either fenofibrate ( 100 mg three times daily ) or matching placebo for 24 weeks .
C0020443
hypercholesterolemia
C0033228
fenofibrate